Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cartwright

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cancer Cell|January 1, 2021
Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast CancerArchis Bagati, Sushil Kumar, Peng Jiang, et al.
The Journal of Pediatrics|March 25, 2025
Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus AdultsSarah E Messiah, Deepali K Ernest, Folefac D Atem, et al.
Pilot and Feasibility Studies|August 2, 2022
Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women's Wellness After Breast Cancer (YWWACP) lifestyle interventionK Sharples, N K Vear, J Porter-Steele, et al.
Annals of the Rheumatic Diseases|August 24, 2011
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypesJasmin B Kuemmerle-Deschner, E Hachulla, R Cartwright, et al.
Frontiers in Immunology|February 21, 2022
Regulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal BacteriaKritika Ramani, Taylor Cormack, Adam N R Cartwright, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Cancer Discovery|March 12, 2021
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T CellsSushil Kumar, Zexian Zeng, Archis Bagati, et al.
British Journal of Cancer|November 20, 2002
Exposure to power frequency electric fields and the risk of childhood cancer in the UKJ Skinner, T J Mee, R P Blackwell, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cancer Cell|January 1, 2021
Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast CancerArchis Bagati, Sushil Kumar, Peng Jiang, et al.
The Journal of Pediatrics|March 25, 2025
Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus AdultsSarah E Messiah, Deepali K Ernest, Folefac D Atem, et al.
Pilot and Feasibility Studies|August 2, 2022
Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women's Wellness After Breast Cancer (YWWACP) lifestyle interventionK Sharples, N K Vear, J Porter-Steele, et al.
Annals of the Rheumatic Diseases|August 24, 2011
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypesJasmin B Kuemmerle-Deschner, E Hachulla, R Cartwright, et al.
Frontiers in Immunology|February 21, 2022
Regulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal BacteriaKritika Ramani, Taylor Cormack, Adam N R Cartwright, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Cancer Discovery|March 12, 2021
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T CellsSushil Kumar, Zexian Zeng, Archis Bagati, et al.
British Journal of Cancer|November 20, 2002
Exposure to power frequency electric fields and the risk of childhood cancer in the UKJ Skinner, T J Mee, R P Blackwell, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Pageof 12